These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 21349594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial.
    Egede R, Jensen LO, Hansen HS, Hansen KN, Junker A, Thayssen P.
    EuroIntervention; 2013 Feb 22; 8(10):1182-9. PubMed ID: 22987572
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Mora S, Glynn RJ, Boekholdt SM, Nordestgaard BG, Kastelein JJ, Ridker PM.
    J Am Coll Cardiol; 2012 Apr 24; 59(17):1521-8. PubMed ID: 22516441
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Statin therapy improves brachial artery endothelial function in nephrotic syndrome.
    Dogra GK, Watts GF, Herrmann S, Thomas MA, Irish AB.
    Kidney Int; 2002 Aug 24; 62(2):550-7. PubMed ID: 12110017
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN, Tuomilehto J, Hamann A, Kallend D, Smith K.
    Diabetes Res Clin Pract; 2004 May 24; 64(2):137-51. PubMed ID: 15063607
    [Abstract] [Full Text] [Related]

  • 10. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.
    Ridker PM, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, Mora S, MacFadyen JG, Glynn RJ, Kastelein JJ, JUPITER Trial Study Group.
    Lancet; 2010 Jul 31; 376(9738):333-9. PubMed ID: 20655105
    [Abstract] [Full Text] [Related]

  • 11. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia.
    Gliozzi M, Walker R, Muscoli S, Vitale C, Gratteri S, Carresi C, Musolino V, Russo V, Janda E, Ragusa S, Aloe A, Palma E, Muscoli C, Romeo F, Mollace V.
    Int J Cardiol; 2013 Dec 10; 170(2):140-5. PubMed ID: 24239156
    [Abstract] [Full Text] [Related]

  • 12. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
    Pirro M, Schillaci G, Romagno PF, Mannarino MR, Bagaglia F, Razzi R, Pasqualini L, Vaudo G, Mannarino E.
    J Cardiovasc Pharmacol Ther; 2009 Mar 10; 14(1):14-21. PubMed ID: 19158317
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia.
    Demir V, Doğru MT, Ede H, Yilmaz S, Alp C, Celik Y, Yildirim N.
    Cardiovasc J Afr; 2009 Mar 10; 29(3):162-166. PubMed ID: 29528361
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX).
    Charbonneau F, Anderson TJ, Title L, Jobin J, Poirier P, Huyhn T, Chan S, Walling A, Hutchison S, Tran T, Lonn E, Buithieu J, Genest J.
    Atherosclerosis; 2008 Mar 10; 197(1):420-7. PubMed ID: 17673219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.